Criteria Used to Determine Platinum Eligibility and First-Line (1L) Treatment (Tx) Patterns Among Platinum-Eligible (Pe) and -Ineligible (Pi) Patients (Pts) with Metastatic Urothelial Cancer (Muc) in France, Germany, Spain, Italy, and the United Kingdom (Eu5).